EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Effect of Notoginsenoside R1 on Insulin-Resistant Polycystic Ovary Syndrome Induced by DHEA and Fructose in Female Albino Wistar Rats

Priyanka Kashyap, Virvikram, Bhupendra Singh, Geetanjali Saini, Jitendra Kumar Mandal, Prince Barwal

BIO Web of Conferences · 2026 · 249 · 00003

DOI: 10.1051/bioconf/202624900003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIO Web of Conferences, online erschienen am 21.08.2026. Verfasst von Priyanka Kashyap und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction, insulin resistance, and metabolic abnormalities. This study aimed to evaluate the therapeutic effect of Notoginsenoside R1 in insulin-resistant PCOS induced by dehydroepiandrosterone (DHEA) and fructose in female Albino Wistar rats. Animals were randomly divided into five groups (n = 6): vehicle control, disease control (DHEA + fructose), low-dose Notoginsenoside R1 (150 mg/kg), high-dose Notoginsenoside R1 (300 mg/kg), and standard treatment with clomiphene citrate (100 mg/kg). The treatment period lasted for 30 days. Body weight, estrous cycle, oral glucose tolerance test (OGTT), and reproductive hormonal parameters including testosterone, estrogen, progesterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) were evaluated. Disease control animals showed typical PCOS features such as increased body weight, elevated testosterone and estrogen levels, reduced progesterone levels, disturbed LH/FSH ratio, and insulin resistance. Treatment with Notoginsenoside R1 significantly improved metabolic and hormonal abnormalities by reducing androgen and estrogen levels, restoring progesterone levels, normalizing the LH/FSH ratio, and improving glucose tolerance.

Zitieren

APA

Kashyap, P., Virvikram, Singh, B., Saini, G., Mandal, J. K., & Barwal, P. (2026). Therapeutic Effect of Notoginsenoside R1 on Insulin-Resistant Polycystic Ovary Syndrome Induced by DHEA and Fructose in Female Albino Wistar Rats. BIO Web of Conferences, 249, 00003. https://doi.org/10.1051/bioconf/202624900003

Vancouver

Kashyap P, Virvikram, Singh B, Saini G, Mandal JK, Barwal P. Therapeutic Effect of Notoginsenoside R1 on Insulin-Resistant Polycystic Ovary Syndrome Induced by DHEA and Fructose in Female Albino Wistar Rats. BIO Web of Conferences. 2026;249:00003. doi:10.1051/bioconf/202624900003

BibTeX
@article{Kashyap2026,
  author = {Kashyap, Priyanka and Virvikram and Singh, Bhupendra and Saini, Geetanjali and Mandal, Jitendra Kumar and Barwal, Prince},
  title = {Therapeutic Effect of Notoginsenoside R1 on Insulin-Resistant Polycystic Ovary Syndrome Induced by DHEA and Fructose in Female Albino Wistar Rats},
  journal = {BIO Web of Conferences},
  year = {2026},
  volume = {249},
  pages = {00003},
  doi = {10.1051/bioconf/202624900003}
}
Kostenlos starten →